Cargando…

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!

Detalles Bibliográficos
Autores principales:	Tiberi, Simon, Cabibbe, Andrea Maurizio, Tomlins, Jennifer, Cirillo, Daniela Maria, Migliori, Giovanni Battista
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925577/ https://www.ncbi.nlm.nih.gov/pubmed/29571835 http://dx.doi.org/10.1016/j.ebiom.2018.02.006

Ejemplares similares

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016)

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Migliori, Giovanni Battista, et al.
Publicado: (2017)

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study
por: Kaniga, Koné, et al.
Publicado: (2020)

Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis
por: Maryandyshev, Andrey, et al.
Publicado: (2017)

Bedaquiline-containing regimens and multidrug-resistant tuberculosis: a systematic review and meta-analysis
por: Hatami, Hossein, et al.
Publicado: (2022)

How To Optimally Combine Genotypic and Phenotypic Drug Susceptibility Testing Methods for Pyrazinamide
por: Köser, Claudio U., et al.
Publicado: (2020)

Circularization of rv0678 for Genotypic Bedaquiline Resistance Testing of Mycobacterium tuberculosis
por: Limberis, Jason D., et al.
Publicado: (2023)

Tuberculosis in the time of COVID-19: quality of life and digital innovation
por: Visca, Dina, et al.
Publicado: (2020)

Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis
por: Rancoita, Paola M. V., et al.
Publicado: (2018)

Fluoroquinolone heteroresistance in Mycobacterium tuberculosis: detection by genotypic and phenotypic assays in experimentally mixed populations
por: Rigouts, L., et al.
Publicado: (2019)

Accelerating development of new shorter TB treatment regimens in anticipation of a resurgence of multi-drug resistant TB due to the COVID-19 pandemic
por: Tiberi, Simon, et al.
Publicado: (2021)

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan
por: Ghodousi, Arash, et al.
Publicado: (2019)

Reply: Roll out of bedaquiline without drug susceptibility testing leads to emergence of bedaquiline-resistance in high burden countries with tuberculosis - Danger of losing a novel drug
por: Jain, Nirmal Kumar
Publicado: (2022)

Monogenic Nephrolithiasis—Collision of Phenotypes, Genotypes, and Phenocopies
por: Mallett, Andrew
Publicado: (2021)

Maleate salts of bedaquiline
por: Zeller, Matthias, et al.
Publicado: (2021)

Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysis
por: Sonnenkalb, Lindsay, et al.
Publicado: (2023)

Coadministration of bedaquiline and pyrifazimine reduce exposure to toxic metabolite N-desmethyl bedaquiline
por: Ding, Yangming, et al.
Publicado: (2023)

Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review
por: Sotgiu, Giovanni, et al.
Publicado: (2016)

Biomarkers of HIV Susceptibility and Disease Progression()
por: Pirrone, Vanessa, et al.
Publicado: (2014)

Management and outcomes of severe childhood tuberculosis in the pediatric intensive care setting: can we identify best practices?
por: Velizarova, Svetlana, et al.
Publicado: (2019)

Crystal structures of salts of bedaquiline
por: Okezue, Mercy, et al.
Publicado: (2020)

Improved Synthesis and Isolation of Bedaquiline
por: Lubanyana, Hlengekile, et al.
Publicado: (2020)

Salts and Polymorph Screens for Bedaquiline
por: Okezue, Mercy, et al.
Publicado: (2021)

Doing the dirty work: progress in the search for a reliable protocol for cardiomyogenesis
por: Redig, Jennifer K, et al.
Publicado: (2011)

Effectiveness and Cardiac Safety of Bedaquiline-Based Therapy for Drug-Resistant Tuberculosis: A Prospective Cohort Study
por: Brust, James C M, et al.
Publicado: (2021)

Genotype to phenotype mapping still needs underpinning by research in metabolism and enzymology
por: Fell, David A.
Publicado: (2018)

Managing severe tuberculosis and its sequelae: from intensive care to surgery and rehabilitation
por: Tiberi, Simon, et al.
Publicado: (2019)

Advantages of long- and short-reads sequencing for the hybrid investigation of the Mycobacterium tuberculosis genome
por: Di Marco, Federico, et al.
Publicado: (2023)

Military genomic testing: proportionality, expected benefits, and the connection between genotypes and phenotypes
por: Pence, Charles H.
Publicado: (2014)

Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus
por: Li, Bing, et al.
Publicado: (2018)

Acquired Resistance of Mycobacterium tuberculosis to Bedaquiline
por: Andries, Koen, et al.
Publicado: (2014)

Correction to “Improved Synthesis and Isolation of Bedaquiline”
por: Lubanyana, Hlengekile, et al.
Publicado: (2020)

Public investments in the clinical development of bedaquiline
por: Gotham, Dzintars, et al.
Publicado: (2020)

Daily Dosing for Bedaquiline in Patients with Tuberculosis
por: Salinger, David H., et al.
Publicado: (2019)

Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Nair, P., et al.
Publicado: (2022)

Primary bedaquiline resistance in Karakalpakstan, Uzbekistan
por: Moe, S., et al.
Publicado: (2023)

Celebrating TB day at the time of COVID-19
por: Alagna, Riccardo, et al.
Publicado: (2020)

Bedaquiline Drug Resistance Emergence Assessment in Multidrug-Resistant Tuberculosis (MDR-TB): a 5-Year Prospective In Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug Susceptibility Testing in MDR-TB Isolates
por: Kaniga, Koné, et al.
Publicado: (2022)

Genotype and Phenotype Correlation in Patients With Dent’s Disease Type 1-Clearing Muddy Waters
por: Mannemuddhu, Sai Sudha, et al.
Publicado: (2023)

Dynamic regulation of tumour progression by phenotype‐switching drivers
por: Vock, Laurenz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r9rf5f5iga5sr6ttnr578osbna